http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2596866-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a26abc2d6306444201a19dc6053b674f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-1491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-01 |
| filingDate | 2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08ae25cfc571c4e799f6a9350e8fe1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d50d539709d27c45a515b09ffa80254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a20c1564389eb5ae0301481480dd3204 |
| publicationDate | 2016-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2596866-C1 |
| titleOfInvention | Method for early prediction of development of postoperative wound infections in the preclinical phase |
| abstract | FIELD: medicine. n SUBSTANCE: invention reates to medicine, namely to surgery, and can be used for early prediction of development of postoperative wound infections in the preclinical phase. For this purpose, every day, starting from the first postoperative day, paravulnar oxygen partial pressure of skin and paravulnar temperature are measured. Also, wound-imprint smear is used to detected the presence of neutrophilic leukocytes, macrophages and fibroblasts. If paravulnar temperature does not tend to decrease, oxygen partial pressure of skin near the wound does not increase, the level of neutrophilic leukocytes rises, level of macrophages decreases, the number of fibroblasts decreases or their development is delayed, the risk of wound abscess can be assessed one-two days prior to any clinical signs. n EFFECT: method provides more effective assessment of risk of surgical wound abscess in the preclinical phase that enables to perform early conservative antimicrobial treatment and stop the transformation of wound infectious process into clinically visible abscess, thereby primary wound healing is possible. n 1 cl, 1 tbl,1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2766406-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2733696-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2777222-C1 |
| priorityDate | 2015-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.